IFF - International Flavors & Fragrances Inc.
NYSE
->
Basic Materials
->
Specialty Chemicals
New York,
United States
Type: Equity
IFF price evolution
IFF
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $671 | $739 | $709 | |
| Short term investments | ||||
| Net receivables | $2061 | $1775 | $2311 | $1726 |
| Inventory | $2200 | $2160 | $2411 | $2477 |
| Total current assets | $8423 | $8149 | $6407 | $6293 |
| Long term investments | ||||
| Property, plant & equipment | $4446 | $4426 | $4870 | $4240 |
| Goodwill & intangible assets | $16163 | $18654 | $18992 | |
| Total noncurrent assets | $21394 | $24235 | $24685 | |
| Total investments | ||||
| Total assets | $29928 | $29543 | $30642 | $30978 |
| Current liabilities | ||||
| Accounts payable | $1462 | $1272 | $1646 | $1378 |
| Deferred revenue | ||||
| Short long term debt | $783 | $1148 | $885 | |
| Total current liabilities | $3218 | $3425 | $3820 | $3758 |
| Long term debt | $8631 | $9216 | $9150 | $9186 |
| Total noncurrent liabilities | $11827 | $12496 | $12578 | |
| Total debt | $9999 | $10949 | $10713 | |
| Total liabilities | $15153 | $15252 | $16351 | $16336 |
| Shareholders' equity | ||||
| Retained earnings | -$2457 | -$2414 | -$2481 | -$2439 |
| Other shareholder equity | -$1760 | -$2315 | -$2191 | $14642 |
| Total shareholder equity | $14254 | $14291 | $14611 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $709 | $493 | $715 | $656.84 |
| Short term investments | ||||
| Net receivables | $1726 | $2159 | $1906 | $929.34 |
| Inventory | $2477 | $3151 | $2516 | $1131.86 |
| Total current assets | $6293 | $7432 | $6987 | $3059.8 |
| Long term investments | ||||
| Property, plant & equipment | $4240 | $4861 | $5135 | $1458.18 |
| Goodwill & intangible assets | $18992 | $22437 | $26920 | $8320.43 |
| Total noncurrent assets | $24685 | $27975 | $32671 | $10495.87 |
| Total investments | ||||
| Total assets | $30978 | $35407 | $39658 | $13555.67 |
| Current liabilities | ||||
| Accounts payable | $1378 | $1674 | $1532 | $555.69 |
| Deferred revenue | ||||
| Short long term debt | $885 | $597 | $632 | $634.16 |
| Total current liabilities | $3758 | $3728 | $3633 | $1903.73 |
| Long term debt | $9186 | $10385 | $11438 | $3779.36 |
| Total noncurrent liabilities | $12578 | $13965 | $14908 | $5328.91 |
| Total debt | $10713 | $11535 | $12070 | $4413.52 |
| Total liabilities | $16336 | $17723 | $18541 | $7232.64 |
| Shareholders' equity | ||||
| Retained earnings | -$2439 | $955 | $3641 | $4156.17 |
| Other shareholder equity | $14642 | -$2169 | -$1423 | -$697.54 |
| Total shareholder equity | $14611 | $17684 | $21082 | $6311.15 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2889 | $2899 | $2703 | |
| Cost of revenue | $1821 | $1875 | ||
| Gross Profit | $1068 | $1024 | $860 | |
| Operating activities | ||||
| Research & development | $173 | $166 | ||
| Selling, general & administrative | $493 | $490 | ||
| Total operating expenses | $1159 | $826 | $768 | |
| Operating income | -$91 | $198 | ||
| Income from continuing operations | ||||
| EBIT | $260 | $197 | ||
| Income tax expense | $11 | $54 | -$32 | |
| Interest expense | $79 | $83 | -$43 | |
| Net income | ||||
| Net income | $170 | $60 | -$2610 | |
| Income (for common shares) | $170 | $60 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $11479 | $12440 | $5084.24 | |
| Cost of revenue | $8289 | $2998.37 | ||
| Gross Profit | $3681 | $4151 | $2085.87 | |
| Operating activities | ||||
| Research & development | $603 | $356.86 | ||
| Selling, general & administrative | $1768 | $948.83 | ||
| Total operating expenses | $3103 | $5477 | $1519.38 | |
| Operating income | -$1326 | $566.48 | ||
| Income from continuing operations | ||||
| EBIT | -$1296 | $569.03 | ||
| Income tax expense | $45 | $239 | $74 | |
| Interest expense | -$380 | $336 | $131.8 | |
| Net income | ||||
| Net income | -$2567 | -$1871 | $363.23 | |
| Income (for common shares) | -$1871 | $363.23 | ||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $170 | $60 | ||
| Operating activities | ||||
| Depreciation | $246 | $278 | ||
| Business acquisitions & disposals | $811 | $37 | ||
| Stock-based compensation | $25 | $18 | ||
| Total cash flows from operations | $237 | $99 | ||
| Investing activities | ||||
| Capital expenditures | -$69 | -$115 | ||
| Investments | ||||
| Total cash flows from investing | $586 | $742 | -$78 | $574 |
| Financing activities | ||||
| Dividends paid | -$411 | -$102 | -$207 | -$826 |
| Sale and purchase of stock | ||||
| Net borrowings | -$910 | $250 | ||
| Total cash flows from financing | -$1444 | -$1063 | $40 | -$1851 |
| Effect of exchange rate | -$10 | -$13 | -$25 | $21 |
| Change in cash and equivalents | -$166 | -$97 | $36 | $183 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$1871 | $270 | $363.23 | |
| Operating activities | ||||
| Depreciation | $1179 | $1156 | $325.36 | |
| Business acquisitions & disposals | $1070 | $361 | ||
| Stock-based compensation | $49 | $54 | $35.8 | |
| Total cash flows from operations | $397 | $1437 | $714.1 | |
| Investing activities | ||||
| Capital expenditures | -$498 | -$379 | -$174.6 | |
| Investments | $173 | -$14.6 | ||
| Total cash flows from investing | $574 | $745 | -$18 | -$187.46 |
| Financing activities | ||||
| Dividends paid | -$826 | -$810 | -$667 | -$322.58 |
| Sale and purchase of stock | $9 | |||
| Net borrowings | -$344 | -$606 | -$147.43 | |
| Total cash flows from financing | -$1851 | -$1229 | -$1304 | -$511.57 |
| Effect of exchange rate | $21 | -$77 | -$59 | $20.86 |
| Change in cash and equivalents | $183 | -$164 | $56 | $35.93 |
News
Fundamentals
| Market cap | $22.96B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 255.70M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.12 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.62 |
| Quick ratio | 1.93 |